Global Microneedles for Trans / Intradermal Drug Delivery Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Microneedles for Trans / Intradermal Drug Delivery market report explains the definition, types, applications, major countries, and major players of the Microneedles for Trans / Intradermal Drug Delivery market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Corium International

    • Clearside Biomedical

    • Zosano Pharma

    • Nanopass Technologies

    • Becton Dickinson

    • BD Medical

    • Valeritas Inc

    • Dr Prausnitz Group

    • Radius Health

    • Circassia

    By Type:

    • Solid Microneedles

    • Hollow Microneedles

    • Dissolvable Microneedles

    By End-User:

    • Drugs

    • Vaccines

    • Proteins

    • Peptides

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Microneedles for Trans / Intradermal Drug Delivery Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Microneedles for Trans / Intradermal Drug Delivery Outlook to 2028- Original Forecasts

    • 2.2 Microneedles for Trans / Intradermal Drug Delivery Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Microneedles for Trans / Intradermal Drug Delivery Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Microneedles for Trans / Intradermal Drug Delivery Market- Recent Developments

    • 6.1 Microneedles for Trans / Intradermal Drug Delivery Market News and Developments

    • 6.2 Microneedles for Trans / Intradermal Drug Delivery Market Deals Landscape

    7 Microneedles for Trans / Intradermal Drug Delivery Raw Materials and Cost Structure Analysis

    • 7.1 Microneedles for Trans / Intradermal Drug Delivery Key Raw Materials

    • 7.2 Microneedles for Trans / Intradermal Drug Delivery Price Trend of Key Raw Materials

    • 7.3 Microneedles for Trans / Intradermal Drug Delivery Key Suppliers of Raw Materials

    • 7.4 Microneedles for Trans / Intradermal Drug Delivery Market Concentration Rate of Raw Materials

    • 7.5 Microneedles for Trans / Intradermal Drug Delivery Cost Structure Analysis

      • 7.5.1 Microneedles for Trans / Intradermal Drug Delivery Raw Materials Analysis

      • 7.5.2 Microneedles for Trans / Intradermal Drug Delivery Labor Cost Analysis

      • 7.5.3 Microneedles for Trans / Intradermal Drug Delivery Manufacturing Expenses Analysis

    8 Global Microneedles for Trans / Intradermal Drug Delivery Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Microneedles for Trans / Intradermal Drug Delivery Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Microneedles for Trans / Intradermal Drug Delivery Export by Region (Top 10 Countries) (2017-2028)

    9 Global Microneedles for Trans / Intradermal Drug Delivery Market Outlook by Types and Applications to 2022

    • 9.1 Global Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Solid Microneedles Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Hollow Microneedles Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Dissolvable Microneedles Consumption and Growth Rate (2017-2022)

    • 9.2 Global Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Drugs Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Vaccines Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Proteins Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Peptides Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Microneedles for Trans / Intradermal Drug Delivery Market Analysis and Outlook till 2022

    • 10.1 Global Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.2.2 Canada Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.2.3 Mexico Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.3.2 UK Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.3.3 Spain Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.3.4 Belgium Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.3.5 France Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.3.6 Italy Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.3.7 Denmark Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.3.8 Finland Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.3.9 Norway Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.3.10 Sweden Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.3.11 Poland Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.3.12 Russia Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.3.13 Turkey Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.4.2 Japan Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.4.3 India Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.4.4 South Korea Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.4.5 Pakistan Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.4.6 Bangladesh Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.4.7 Indonesia Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.4.8 Thailand Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.4.9 Singapore Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.4.10 Malaysia Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.4.11 Philippines Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.4.12 Vietnam Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.5.2 Colombia Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.5.3 Chile Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.5.4 Argentina Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.5.5 Venezuela Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.5.6 Peru Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.5.7 Puerto Rico Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.5.8 Ecuador Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.6.2 Kuwait Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.6.3 Oman Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.6.4 Qatar Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.7.2 South Africa Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.7.3 Egypt Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.7.4 Algeria Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

      • 10.8.2 New Zealand Microneedles for Trans / Intradermal Drug Delivery Consumption (2017-2022)

    11 Global Microneedles for Trans / Intradermal Drug Delivery Competitive Analysis

    • 11.1 Corium International

      • 11.1.1 Corium International Company Details

      • 11.1.2 Corium International Microneedles for Trans / Intradermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Corium International Microneedles for Trans / Intradermal Drug Delivery Main Business and Markets Served

      • 11.1.4 Corium International Microneedles for Trans / Intradermal Drug Delivery Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Clearside Biomedical

      • 11.2.1 Clearside Biomedical Company Details

      • 11.2.2 Clearside Biomedical Microneedles for Trans / Intradermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Clearside Biomedical Microneedles for Trans / Intradermal Drug Delivery Main Business and Markets Served

      • 11.2.4 Clearside Biomedical Microneedles for Trans / Intradermal Drug Delivery Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Zosano Pharma

      • 11.3.1 Zosano Pharma Company Details

      • 11.3.2 Zosano Pharma Microneedles for Trans / Intradermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Zosano Pharma Microneedles for Trans / Intradermal Drug Delivery Main Business and Markets Served

      • 11.3.4 Zosano Pharma Microneedles for Trans / Intradermal Drug Delivery Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Nanopass Technologies

      • 11.4.1 Nanopass Technologies Company Details

      • 11.4.2 Nanopass Technologies Microneedles for Trans / Intradermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Nanopass Technologies Microneedles for Trans / Intradermal Drug Delivery Main Business and Markets Served

      • 11.4.4 Nanopass Technologies Microneedles for Trans / Intradermal Drug Delivery Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Becton Dickinson

      • 11.5.1 Becton Dickinson Company Details

      • 11.5.2 Becton Dickinson Microneedles for Trans / Intradermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Becton Dickinson Microneedles for Trans / Intradermal Drug Delivery Main Business and Markets Served

      • 11.5.4 Becton Dickinson Microneedles for Trans / Intradermal Drug Delivery Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 BD Medical

      • 11.6.1 BD Medical Company Details

      • 11.6.2 BD Medical Microneedles for Trans / Intradermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 BD Medical Microneedles for Trans / Intradermal Drug Delivery Main Business and Markets Served

      • 11.6.4 BD Medical Microneedles for Trans / Intradermal Drug Delivery Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Valeritas Inc

      • 11.7.1 Valeritas Inc Company Details

      • 11.7.2 Valeritas Inc Microneedles for Trans / Intradermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Valeritas Inc Microneedles for Trans / Intradermal Drug Delivery Main Business and Markets Served

      • 11.7.4 Valeritas Inc Microneedles for Trans / Intradermal Drug Delivery Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Dr Prausnitz Group

      • 11.8.1 Dr Prausnitz Group Company Details

      • 11.8.2 Dr Prausnitz Group Microneedles for Trans / Intradermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Dr Prausnitz Group Microneedles for Trans / Intradermal Drug Delivery Main Business and Markets Served

      • 11.8.4 Dr Prausnitz Group Microneedles for Trans / Intradermal Drug Delivery Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Radius Health

      • 11.9.1 Radius Health Company Details

      • 11.9.2 Radius Health Microneedles for Trans / Intradermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Radius Health Microneedles for Trans / Intradermal Drug Delivery Main Business and Markets Served

      • 11.9.4 Radius Health Microneedles for Trans / Intradermal Drug Delivery Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Circassia

      • 11.10.1 Circassia Company Details

      • 11.10.2 Circassia Microneedles for Trans / Intradermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Circassia Microneedles for Trans / Intradermal Drug Delivery Main Business and Markets Served

      • 11.10.4 Circassia Microneedles for Trans / Intradermal Drug Delivery Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    12 Global Microneedles for Trans / Intradermal Drug Delivery Market Outlook by Types and Applications to 2028

    • 12.1 Global Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Solid Microneedles Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Hollow Microneedles Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Dissolvable Microneedles Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Drugs Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Proteins Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Peptides Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Microneedles for Trans / Intradermal Drug Delivery Market Analysis and Outlook to 2028

    • 13.1 Global Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.2.2 Canada Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.3.2 UK Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.3.3 Spain Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.3.5 France Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.3.6 Italy Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.3.8 Finland Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.3.9 Norway Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.3.11 Poland Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.3.12 Russia Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.4.2 Japan Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.4.3 India Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.5.3 Chile Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.5.6 Peru Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.6.3 Oman Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Microneedles for Trans / Intradermal Drug Delivery

    • Figure of Microneedles for Trans / Intradermal Drug Delivery Picture

    • Table Global Microneedles for Trans / Intradermal Drug Delivery Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Microneedles for Trans / Intradermal Drug Delivery Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Solid Microneedles Consumption and Growth Rate (2017-2022)

    • Figure Global Hollow Microneedles Consumption and Growth Rate (2017-2022)

    • Figure Global Dissolvable Microneedles Consumption and Growth Rate (2017-2022)

    • Figure Global Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Proteins Consumption and Growth Rate (2017-2022)

    • Figure Global Peptides Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Microneedles for Trans / Intradermal Drug Delivery Consumption by Country (2017-2022)

    • Table North America Microneedles for Trans / Intradermal Drug Delivery Consumption by Country (2017-2022)

    • Figure United States Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Canada Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Mexico Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Table Europe Microneedles for Trans / Intradermal Drug Delivery Consumption by Country (2017-2022)

    • Figure Germany Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure UK Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Spain Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Belgium Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure France Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Italy Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Denmark Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Finland Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Norway Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Sweden Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Poland Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Russia Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Turkey Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Table APAC Microneedles for Trans / Intradermal Drug Delivery Consumption by Country (2017-2022)

    • Figure China Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Japan Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure India Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure South Korea Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Thailand Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Singapore Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Philippines Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Table South America Microneedles for Trans / Intradermal Drug Delivery Consumption by Country (2017-2022)

    • Figure Brazil Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Colombia Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Chile Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Argentina Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Peru Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Table GCC Microneedles for Trans / Intradermal Drug Delivery Consumption by Country (2017-2022)

    • Figure Bahrain Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Oman Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Qatar Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Table Africa Microneedles for Trans / Intradermal Drug Delivery Consumption by Country (2017-2022)

    • Figure Nigeria Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure South Africa Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Egypt Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Algeria Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Table Oceania Microneedles for Trans / Intradermal Drug Delivery Consumption by Country (2017-2022)

    • Figure Australia Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Microneedles for Trans / Intradermal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Table Corium International Company Details

    • Table Corium International Microneedles for Trans / Intradermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Corium International Microneedles for Trans / Intradermal Drug Delivery Main Business and Markets Served

    • Table Corium International Microneedles for Trans / Intradermal Drug Delivery Product Portfolio

    • Table Clearside Biomedical Company Details

    • Table Clearside Biomedical Microneedles for Trans / Intradermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Clearside Biomedical Microneedles for Trans / Intradermal Drug Delivery Main Business and Markets Served

    • Table Clearside Biomedical Microneedles for Trans / Intradermal Drug Delivery Product Portfolio

    • Table Zosano Pharma Company Details

    • Table Zosano Pharma Microneedles for Trans / Intradermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Zosano Pharma Microneedles for Trans / Intradermal Drug Delivery Main Business and Markets Served

    • Table Zosano Pharma Microneedles for Trans / Intradermal Drug Delivery Product Portfolio

    • Table Nanopass Technologies Company Details

    • Table Nanopass Technologies Microneedles for Trans / Intradermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nanopass Technologies Microneedles for Trans / Intradermal Drug Delivery Main Business and Markets Served

    • Table Nanopass Technologies Microneedles for Trans / Intradermal Drug Delivery Product Portfolio

    • Table Becton Dickinson Company Details

    • Table Becton Dickinson Microneedles for Trans / Intradermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Becton Dickinson Microneedles for Trans / Intradermal Drug Delivery Main Business and Markets Served

    • Table Becton Dickinson Microneedles for Trans / Intradermal Drug Delivery Product Portfolio

    • Table BD Medical Company Details

    • Table BD Medical Microneedles for Trans / Intradermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table BD Medical Microneedles for Trans / Intradermal Drug Delivery Main Business and Markets Served

    • Table BD Medical Microneedles for Trans / Intradermal Drug Delivery Product Portfolio

    • Table Valeritas Inc Company Details

    • Table Valeritas Inc Microneedles for Trans / Intradermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Valeritas Inc Microneedles for Trans / Intradermal Drug Delivery Main Business and Markets Served

    • Table Valeritas Inc Microneedles for Trans / Intradermal Drug Delivery Product Portfolio

    • Table Dr Prausnitz Group Company Details

    • Table Dr Prausnitz Group Microneedles for Trans / Intradermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dr Prausnitz Group Microneedles for Trans / Intradermal Drug Delivery Main Business and Markets Served

    • Table Dr Prausnitz Group Microneedles for Trans / Intradermal Drug Delivery Product Portfolio

    • Table Radius Health Company Details

    • Table Radius Health Microneedles for Trans / Intradermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Radius Health Microneedles for Trans / Intradermal Drug Delivery Main Business and Markets Served

    • Table Radius Health Microneedles for Trans / Intradermal Drug Delivery Product Portfolio

    • Table Circassia Company Details

    • Table Circassia Microneedles for Trans / Intradermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Circassia Microneedles for Trans / Intradermal Drug Delivery Main Business and Markets Served

    • Table Circassia Microneedles for Trans / Intradermal Drug Delivery Product Portfolio

    • Figure Global Solid Microneedles Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hollow Microneedles Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Dissolvable Microneedles Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Proteins Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Peptides Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast by Country (2022-2028)

    • Table North America Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast by Country (2022-2028)

    • Figure United States Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast by Country (2022-2028)

    • Figure Germany Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast by Country (2022-2028)

    • Figure China Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast by Country (2022-2028)

    • Figure Brazil Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast by Country (2022-2028)

    • Figure Australia Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Microneedles for Trans / Intradermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.